Objective To explore the improvement of short-term focus group therapy (FBGT) on interpersonal problems and depressive symptoms in patients with mild to moderate depression.Methods A total of 60 patients with mild to moderate depression were randomly divided into the study group (30 cases)and the control group (30 cases).The study group received 8 short-term focus group treatments while taking the original drugs，and the control group received health education while taking the original drugs.Results The SDS score of the study group was significantly lower than that of the control group (P＜0.05).The total score of IIP-32 and the factor scores PA，BC，DE，FG，HI，JK，LM and no in the study group were improved compared with those in the control group (P＜0.05).Conclusion Short term focus group therapy can improve the interpersonal problems and depressive symptoms of patients with depression.

Objective: To investigate the clinical efficacy of quetiapine fumarate combined with aripiprazole in the treatment of schizophrenia. Methods: From February 2020 to October 2021, 80 patients with schizophrenia who were admitted to the Psychiatry Department of Ping''an Hospital, Xicheng District, Beijing, were selected as the observation objects. According to the random number table method, they were divided into control group and observation group, with 40 cases in each group. The control group was treated with quetiapine fumarate, and the observation group was treated with quetiapine fumarate combined with aripiprazole. The course of treatment for each group was 8 weeks. The clinical efficacy, positive and negative syndrome scale (PANSS) scores and quality of life scores were compared between the two groups. Results: The total effective rate of clinical efficacy in the observation group was higher than that in the control group, and the difference was statistically significant (P＜0.05). After treatment, the PANSS positive symptom score, negative symptom score, psychopathological score and total score were all lower than those in the control group, and the scores of cognitive function, emotional function, physical function, role function and social function were higher than those in the control group, and the difference was statistically significant. (P＜0.05). Conclusion: Quetiapine fumarate combined with aripiprazole in the treatment of schizophrenia has high clinical efficacy and can significantly improve the cognitive function and quality of life of patients.

Objective To observe the effect of rehabilitation training combined with dietary intervention on bone mineral density in patients with chronic schizophrenia. Methods A totalof 128 long-term hospitalized patients with chronic schizophrenic were divided by random number table method into control group and research group, with 64 cases in each group. The research group received rehabilitation training combined with dietary intervention, and the control group received conventional intervention. Comparison were made on nutrient intake after intervention, changes of bone mineral density before and after intervention and occurrence of fragile fracture between the two groups. Results After intervention, the research group had higher intake of protein, calcium, phosphorus and vitamin A, D and other nutrients than the control group, and the difference was statistically significant (P<0.05) . After intervention, both groups had higher bone mineral density of lumbar spine and left femoral neck, and the research group had significantly higher bone mineral density than the control group. Their difference was statistically significant (P<0.05) . After 6 months of follow-up, the control group had 7 cases of fragile fracture (10.94％) , and the research group had 1 case of fragile fracture (1.61％) . The research group had lower incidence of fragile fracture than the control group, and the difference was statistically significant (P<0.05) . Conclusion Combination of dietary intervention and targeted rehabilitation training can improve the bone mineral density of patients with schizophrenia and reduce the incidence of fragile fracture.

目的探讨心理干预对乳腺增生症的辅助疗效。方法将256例患者随机分为研究组和对照组,各128例,对研究组患者采用心理干预、药物治疗;对照组仅采用药物治疗。依据1998年全国中医外科学会第二次乳腺疾病学术会议标准评价及汉密顿评定量表进行评定。结果两组患者疗效比较,差异有统计学意义(χ2=8.99,P<0.01),干预后0.5、1、2 a两组患者焦虑情绪(HAMA评分)差异有统计学意义(t值分别为8.33、8.54、5.34,P<0.01)。结论心理干预能够改善病人焦虑紧张情绪,使患者积极配合治疗,提高治疗效果,促进康复。

目的探讨精神病人对医务人员服务的满意度.方法以2004年1～6月512例门诊、出院精神病人作为信访对象,用枣庄市卫生局统一设计的"门诊、出院病人医疗服务质量信息反馈表"进行信访问卷.结果标准收费、拒受宴请、医疗效果满意度较低,分别为80.2%、83.9%、89.4%.结论医院要按价收费、加强医德医风教育、提高医生诊疗技术.

目的观察利培酮与氯丙嗪对病人血压、心率的影响.方法将100例精神分裂症患者随机分成研究组和对照组,分别给予利培酮及氯丙嗪治疗,采用omRon电子血压计,测量患者入院1、7、14、21 d不同体位的血压、心率及评定副反应量表.结果研究组优于对照组,且有11例发生体位性低血压,其中研究组3例,对照组8例;研究组直立位较平卧位血压低0.71～1.82 kPa,心率快8～15次/min;两组副反应比较,差异有非常显著性(P＜0.01).结论利培酮较氯丙嗪对患者血压、心率影响小,体位性低血压发生率低,副反应轻.

目的 探讨全程综合干预措施对女性精神分裂症患者病程及愈后的影响.方法将200例女性精神分裂症患者随机分为研究组和对照组,各100例,对研究组患者实施全程综合干预措施1年.分别于入组时、6个月后和1年后进行评估并比较,采用护士用住院病人观察量表,阳性和阴性症状量表,生活质量综合评定问卷,简明精神病量表,社会功能缺陷筛选量表作为评定工具.结果患者阴性症状和阳性症状明显缓解,其评分结果分别为:入组时,研究组(29.13±6.62)分,(27.12±7.86)分;对照组(28.48±6.89)分,(26.89±7.33)分,P＞0.05.6个月时研究组(15.38±5.46)分,(10.12±5.34)分;对照组(19.01±5.32)分,(15.78±5.65)分,P＜0.01.1年时研究组(10.98±5.31)分,(8.19±5.64)分,对照组(13.37±5.12)分,(15.12±5.21)分,P＜0.01.入组时所有量表评分两组间差异无显著性意义(P＞0.05),6个月和1年后除简明精神病量表中激活性1项评分两组间差异无显著性意义(P＞0.05),其他各项评分及护士用住院病人观察量表、阳性和阴性症状量表、生活质量综合评定问卷和社会功能缺陷筛选量表评分两组间差异有显著性意义(P＜0.05)和差异有非常显著性意义(P＜0.01).结论全程综合干预措施能够缓解女性精神分裂症患者的精神症状,缩短住院日程,促进社会功能恢复,提高其生活质量。